转录因子Kaiso下调人乳腺癌细胞系中lncRNA MEG3的表达

doi:10.16352/j.issn.1001-6325.2022.05.024

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (5): 758-762.doi: 10.16352/j.issn.1001-6325.2022.05.024

转录因子Kaiso下调人乳腺癌细胞系中lncRNA MEG3的表达

谢利华, 杨奇, 李雅倩, 谢心悦, 雷诗娟, 周琳^*

长沙医学院医学检验学院临床生物化学教研室, 湖南长沙 410219

收稿日期:2020-08-23 修回日期:2021-04-13 出版日期:2022-05-05 发布日期:2022-04-28
通讯作者: * Linzhou12@126.com
基金资助:
湖南省自然科学基金(2020JJ5625);湖南省教育厅一般项目(18C1182); 湖南省大学生创新性课题(S201910823019);湖南省卫健委科研计划课题(20190473)

Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines

XIE Li-hua, YANG Qi, LI Ya-qian, XIE Xin-yue, LEI Shi-juan, ZHOU Lin^*

Department of Clinical Biochemistry, Clinical Laboratory Medicine of Changsha Medical University, Changsha 410219,China

Received:2020-08-23 Revised:2021-04-13 Online:2022-05-05 Published:2022-04-28
Contact: * Linzhou12@126.com

摘要/Abstract

摘要： 目的探讨转录因子 Kaiso 是否调节人母系表达基因3(MEG3)表达及其在乳腺癌的发生发展中发挥重要作用。方法 RT-qPCR 检测正常乳腺细胞系MCF-10A和多个乳腺癌细胞系MCF-7、BT-474、MDA-MB-435、MDA-MB-231中 Kaiso 和 MEG3 的表达;蛋白印迹检测Kaiso在各种细胞中的表达;免疫组织化学检测50例乳腺癌和癌旁组织中Kaiso表达; RT-qPCR检测过表达Kaiso对母系印记基因编码的长链非编码RNA(lncRNA MEG3)转录水平的影响。结果 MCF-10A中lncRNA MEG3转录水平高于Kaiso的转录水平(P＜0.001),在MCF-7、BT-474、MDA-MB-435、MDA-MB-231细胞中Kaiso明显上调,而lncRNA MEG3明显下调(P＜0.001);MCF-10A中Kaiso表达水平较低,而在MDA-MB-231高转移性乳腺癌细胞中呈现出高表达状态(P＜0.05)。Kaiso在乳腺癌旁组织中为低表达(P＜0.001),而在癌组织中高表达于细胞质与细胞核中。另外在MCF-10A细胞中使Kaiso过表达后lncRNA MEG3的转录水平明显下调(P＜0.01)。结论 Kaiso调节lncRNA MEG3在乳腺癌组织细胞中的表达,在乳腺癌的发生发展中可能发挥重要作用。

关键词: Kaiso, 长链非编码RNA(lncRNA), 母系表达基因3(MEG3), 乳腺癌

Abstract: Objective To investigate the potential regualation of the expression of human maternal gene 3(MEG3) by transcription factor Kaiso and the impact on the occurrence and development of breast cancer. Methods The expression of Kaiso and MEG3 in breast cell line MCF-10a and different breast cancer cell lines MCF-7,BT-474,MDA-MB-435,MDA-MB-231 were detected by RT-qPCR. The expression of Kaiso in cells was detected by Western blot.Kaiso expression of 50 samples from cancer and paracancer tissues were examined by Western blot. RT-qPCR was used to detect the effect of Kaiso over-expressed on the transcription of long non-coding RNA(lncRNA) MEG3. Results The transcription of lncRNA MEG3 in MCF-10a was higher than that of Kaiso (P＜0.001). Kaiso was significantly up-regulated in MCF-7, BT-474, MDA-MB-435, and MDA-MB-231 breast cancer cells,while lncRNA MEG3 was significantly down-regulated (P＜0.001). Kaiso expression level was low in MCF-10a, but was high in MDA-MB-231 highly metastatic breast cancer (P＜0.05). Kaiso was low in paracancerous breast tissues (P＜0.001), but highly expressed in cytoplasm and nucleus in cancer tissues. In addition, Kaiso over-expression in MCF-10a significantly down regulated the transcription of lncRNA MEG3(P＜0.01). Conclusions Kaiso regulates the expression of lncRNA MEG3 by breast cancer cells, which may play an important role in the occurrence and development of breast cancer.

Key words: Kaiso, long non-coding RNA(lncRNA), maternally expressed gene 3(MEG3), breast cancer

中图分类号:

R737.9

谢利华, 杨奇, 李雅倩, 谢心悦, 雷诗娟, 周琳. 转录因子Kaiso下调人乳腺癌细胞系中lncRNA MEG3的表达[J]. 基础医学与临床, 2022, 42(5): 758-762.

XIE Li-hua, YANG Qi, LI Ya-qian, XIE Xin-yue, LEI Shi-juan, ZHOU Lin. Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines[J]. Basic & Clinical Medicine, 2022, 42(5): 758-762.

参考文献

[1] 张花样,孙惠听,宋冰冰.2008-2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J].用肿瘤学杂,2019,33:261-265.
[2] Benetato L,Vartholomatos G,Hatzimichael E.MEG3 imprinted gene contribution in tumorigenesis[J].Int J Cancer,2011,129:733-779.
[3] Oas RG,Nanes BA,Esimai CC,et al.p120-catenin and β-catenin differentially regulate cadherin adhesive function[J].MolBiol Cell,2013,24:704-714.
[4] Zhou Y,Zhang X,Klibanski A.MEG3 noncoding RNA: a tumor suppressor[J].Mol Endocrinol,2012,48: R45-R53.
[5] 邹子归,周晋星,马天时,等.长链非编码RNA调控乳腺癌侵袭与转移的研究进展.[J].基础医学与临床,2018,38,573-577.
[6] Zhang W, Shi S, Jiang J,et al.LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer[J]. Biomed Pharmacother,2017,91:312-319.
[7] Vermeulen JF,van de Ven RA,Ercan C,et al.Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer[J].PLoS One,2012,7:e37864.doi: 10.1371/journal.pone.0037864.
[8] 周琳,杨芳慧,周江,等.乳腺癌组织中 Kaiso 和糖皮质激素受体的表达及临床意义[J].临床检验杂志,2015,33:115-118.
[9] Ruzov A,Savitskaya E,Hackett JA,et al.The non-methylatedDNA-binding function of Kaiso is not required in early Xenopuslaevis development[J].Development,2009,136:729-738.
[10] O'Donnell JJ,Zhuge Y,Holian O,et al.Loss of p120 cateninupregulates transcription of pro-inflammatory adhesion moleculesin human endothelial cells[J].Microvasc Res,2011,82:105-112.
[11] Ven RA, Tenhagen M, Meuleman W, et al.Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11 expression[J]. Dis Model Mech. 2015,8:373-384.
[12] Xu W,Kimelman D.Mechanistic insights from structural studies ofbeta-catenin and its binding partners[J].J Cell Sci,2007,120: 3337-3344.
[13] 刘洋,苗原,韩强,等.p120-catenin 通过Kaiso 在转录水平上调控肺癌细胞系LTEP-a-2中β-catenin 的表达[J].现代肿瘤医学,2016,24:1845-1850.
[14] Zhang L, Gallup M, Zlock L, et al.Cigarette smoke mediates nuclear to cytoplasmic trafficking of transcriptional inhibitor Kaiso through MUC1 and P120-catenin[J].Am J Pathol,2016,186:3146-3159.
[15] Pierre CC, Longo J, Mavor M, et al.Kaiso overexpression promotes intestinal inflammation and potentiates intestinal tumorigenesis in Apc(Min/+) mice[J].Biochim Biophys Acta,2015,1852:1846-1855.
[16] Zhou L, Zhong Y, Yang FH,et al.Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells[J]. BMB Rep,2016,49:167-172.

转录因子Kaiso下调人乳腺癌细胞系中lncRNA MEG3的表达

Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	苏凌峰, 王虎霞, 王延峰, 宋张骏. 慢性压力对乳腺癌发展的影响[J]. 基础医学与临床, 2024, 44(9): 1303-1307.
[2]	夏雨佳, 杨振丽, 代娣, 刘玉琴. 乳腺癌类器官的培养及鉴定[J]. 基础医学与临床, 2024, 44(9): 1223-1228.
[3]	陆凯, 陆建菊, 郭文利, 黄建棋, 李志华. lncRNA VIM-AS5在人乳腺癌细胞系中的表达及对乳腺癌细胞增殖和迁移的影响[J]. 基础医学与临床, 2024, 44(4): 447-453.
[4]	南璐, 郭梦杰, 高雅楠, 贾红燕. 膜联蛋白A家族成员在乳腺癌中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(3): 393-397.
[5]	依合里曼·买买提, 曹燕珍, 王翠翠, 岳娜, 梁莉萍. PIK3CA突变与乳腺癌临床病理特征及预后的相关性[J]. 基础医学与临床, 2024, 44(3): 303-307.
[6]	李江丽, 孙静, 唐一君, 郭君兰, 陈博, 郭胜男. Circ-DDX5靶向miR-3940抑制人乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2024, 44(1): 1-7.
[7]	陈宁, 彭甜影, 张伟苗, 高亚诺, 李轩, 闫彩珍, 李军霞. 雷公藤甲素与阿霉素联用对人乳腺癌细胞系 MCF-7 的协同促凋亡作用[J]. 基础医学与临床, 2023, 43(8): 1186-1192.
[8]	王继辉, 曹吉烈, 张立军, 张军, 鹿文葆. TARBP2降解AKAP12转录本促进人乳腺癌细胞转移[J]. 基础医学与临床, 2023, 43(8): 1259-1264.
[9]	唐一君, 王文龙, 李江丽, 杨欢, 孙静. LncRNA RP11-686D22.10与乳腺癌患者生存期相关并影响乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2023, 43(7): 1023-1029.
[10]	杨良权, 于淼, 姜茜, 张明慧, 杨海松. miR-504调控蛋白酶体激活因子抑制人乳腺癌细胞系MCF-7增殖及迁移[J]. 基础医学与临床, 2023, 43(1): 95-101.
[11]	王群, 李鑫, 马俊, 李婉明. 核酸适配体W3介导靶向乳腺癌的量子点成像[J]. 基础医学与临床, 2023, 43(1): 76-82.
[12]	张晓雷, 刘静, 李朝萍. Circ_0032821参与索拉非尼抑制乳腺癌细胞系T47D增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(9): 1350-1354.
[13]	王子辕, 段昭君, 罗云萍. 小鼠乳腺癌肺特异性转移细胞亚系的建立和验证[J]. 基础医学与临床, 2022, 42(7): 1083-1091.
[14]	韩雪莹, 崔丰, 李隽. 乳腺癌缺失因子1(DBC1)影响乳腺癌细胞系对依托泊苷的敏感性[J]. 基础医学与临床, 2022, 42(7): 1060-1066.
[15]	康有力, 赵丹, 杜文静, 李莉. SIRT5通过调控ALDH5A1的琥珀酰化促进人乳腺癌细胞的增殖[J]. 基础医学与临床, 2022, 42(7): 1099-1107.